Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lycopene cancer study

This article was originally published in The Tan Sheet

Executive Summary

Consumption of tomato products, but not lycopene alone, inhibited the onset of prostate cancer in rats, reports a study published in the Nov. 5 Journal of the National Cancer Institute. Steven Clinton, MD/PhD, et al. found male rats on tomato-based diets demonstrated lower mortality rate than rats in control and lycopene groups. Results suggest "tomato phytochemicals and diet restriction may act by independent mechanisms" to reduce prostate cancer risk. Supplement marketer American Longevity filed a petition in June for approval of cancer risk reduction claims on lycopene, tomatoes and tomato-based products (1"The Tan Sheet" June 9, 2003, p. 17)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel